{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:03:03Z","timestamp":1786752183494,"version":"build-2736575974"},"reference-count":33,"publisher":"China Science Publishing & Media Ltd.","issue":"12","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1093\/abbs\/gmu103","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T07:34:17Z","timestamp":1415345657000},"page":"1024-1033","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":88,"title":["Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway"],"prefix":"10.3724","volume":"46","author":[{"given":"Jing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"null","first-page":"302","volume":"37","author":"Silva I","year":"2012","unstructured":"Silva I, Branco JC. Denosumab: recent update in postmenopausal osteoporosis. Acta Reumatol Port, 2012, 37: 302-313.","journal-title":"Acta Reumatol Port"},{"key":"null","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0253-7613.115008","volume":"45","author":"Yilmaz M","year":"2013","unstructured":"Yilmaz M, Isaoglu U, Uslu T, Yildirim K, Seven B, Akcay F, Hacimuftuoglu A. Effect of methylprednisolone on bone mineral density in rats with ovariectomy-induced bone loss and suppressed endogenous adrenaline levels by metyrosine. Indian J Pharmacol, 2013, 45: 344-347.","journal-title":"Indian J Pharmacol"},{"key":"null","first-page":"1313","volume":"8","author":"Noguchi Y","year":"2013","unstructured":"Noguchi Y, Kawate H, Nomura M, Takayanagi R. Eldecalcitol for the treatment of osteoporosis. Clin Interv Aging, 2013, 8: 1313-1321.","journal-title":"Clin Interv Aging"},{"key":"null","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1471-2474-14-253","volume":"14","author":"Muir JM","year":"2013","unstructured":"Muir JM, Ye C, Bhandari M, Adachi JD, Thabane L. The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study. BMC Musculoskelet Disord, 2013, 14:","journal-title":"BMC Musculoskelet Disord"},{"key":"null","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"Raisz LG","year":"2005","unstructured":"Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest, 2005, 115: 3318-3325.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Rossouw JE","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 2002, 288: 321-333.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2012.10.525","volume":"56","author":"Morris BJ","year":"2013","unstructured":"Morris BJ. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med, 2013, 56: 133-171.","journal-title":"Free Radic Biol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.bcp.2012.06.031","volume":"84","author":"Yao H","year":"2012","unstructured":"Yao H, Rahman I. Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol, 2012, 84: 1332-1339.","journal-title":"Biochem Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ypmed.2011.11.014","volume":"54","author":"Rahman I","year":"2012","unstructured":"Rahman I, Kinnula VL, Gorbunova V, Yao H. SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev Med, 2012, 54: S20-S28.","journal-title":"Prev Med"},{"key":"null","first-page":"635","volume":"4","author":"Guerrero RF","year":"2009","unstructured":"Guerrero RF, Garcia-Parrilla MC, Puertas B, Cantos-Villar E. Wine, resveratrol and health: a review. Nat Prod Commun, 2009, 4: 635-658.","journal-title":"Nat Prod Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.12145","volume":"1290","author":"Mobasheri A","year":"2013","unstructured":"Mobasheri A, Shakibaei M. Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis. Ann N Y Acad Sci, 2013, 1290: 59-66.","journal-title":"Ann N Y Acad Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbrc.2010.09.053","volume":"401","author":"He X","year":"2010","unstructured":"He X, Andersson G, Lindgren U, Li Y. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun, 2010, 401: 356-362.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1074\/jbc.M110.198713","volume":"286","author":"Shakibaei M","year":"2011","unstructured":"Shakibaei M, Buhrmann C, Mobasheri A. Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem, 2011, 286: 11492-11505.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156720210791184899","volume":"7","author":"Hou J","year":"2010","unstructured":"Hou J, Chong ZZ, Shang YC, Maiese K. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res, 2010, 7: 95-112.","journal-title":"Curr Neurovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1210\/en.2010-0399","volume":"151","author":"Alles N","year":"2010","unstructured":"Alles N, Soysa NS, Hayashi J, Khan M, Shimoda A, Shimokawa H, Ritzeler O. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology, 2010, 151: 4626-4634.","journal-title":"Endocrinology"},{"key":"null","first-page":"875","volume":"51","author":"French L","year":"2002","unstructured":"French L, Smith M, Shimp L. Prevention and treatment of osteoporosis in postmenopausal women. J Fam Pract, 2002, 51: 875-882.","journal-title":"J Fam Pract"},{"key":"null","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11914-004-0018-y","volume":"2","author":"Selby P","year":"2004","unstructured":"Selby P. Postmenopausal osteoporosis. Curr Osteoporos Rep, 2004, 2: 101-106.","journal-title":"Curr Osteoporos Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"Kanis JA","year":"1994","unstructured":"Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int, 1994, 4: 368-381.","journal-title":"WHO Study Group. Osteoporos Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.ID.0000116456.76235.BC","volume":"13","author":"Cho P","year":"2004","unstructured":"Cho P, Schneider GB, Krizan K, Keller JC. Examination of the bone-implant interface in experimentally induced osteoporotic bone. Implant Dent, 2004, 13: 79-87.","journal-title":"Implant Dent"},{"key":"null","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3177\/jnsv.46.78","volume":"46","author":"Mizutani K","year":"2000","unstructured":"Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo), 2000, 46: 78-83.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"null","doi-asserted-by":"crossref","first-page":"76","DOI":"10.59566\/IJBS.2005.1076","volume":"1","author":"Lin Q","year":"2005","unstructured":"Lin Q, Huang YM, Xiao BX, Ren GF. Effects of resveratrol on bone mineral density in ovarectomized rats. Int J Biomed Sci, 2005, 1: 76-81.","journal-title":"Int J Biomed Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1017\/S0007114513003115","volume":"111","author":"Zhao H","year":"2014","unstructured":"Zhao H, Li X, Li N, Liu T, Liu J, Li Z, Xiao H. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. Br J Nutr, 2014, 111: 836-846.","journal-title":"Br J Nutr"},{"key":"null","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jmbbm.2011.08.014","volume":"11","author":"Dosier CR","year":"2012","unstructured":"Dosier CR, Erdman CP, Park JH, Schwartz Z, Boyan BD, Guldberg RE. Resveratrol effect on osteogenic differentiation of rat and human adipose derived stem cells in a 3-D culture environment. J Mech Behav Biomed Mater, 2012, 11: 112-122.","journal-title":"J Mech Behav Biomed Mater"},{"key":"null","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4093\/dmj.2013.37.5.315","volume":"37","author":"Kitada M","year":"2013","unstructured":"Kitada M, Koya D. SIRT1 in Type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J, 2013, 37: 315-325.","journal-title":"Diabetes Metab J"},{"key":"null","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clon.2013.01.008","volume":"25","author":"Vassiliou V","year":"2013","unstructured":"Vassiliou V. Management of metastatic bone disease in the elderly with bisphosphonates and receptor activator of NF-\u03baB ligand inhibitors: effectiveness and safety. Clin Oncol (R Coll Radiol), 2013, 25: 290-297.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"null","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jbmr.2108","volume":"29","author":"Yao Z","year":"2014","unstructured":"Yao Z, Li Y, Yin X, Dong Y, Xing L, Boyce BF. NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J Bone Miner Res, 2014, 29: 866-877.","journal-title":"J Bone Miner Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/cbin.10141","volume":"37","author":"Feng X","year":"2013","unstructured":"Feng X, Feng G, Xing J, Shen B, Li L, Tan W, Xu Y. TNF-alpha triggers osteogenic differentiation of human dental pulp stem cells via the NF-kappaB signalling pathway. Cell Biol Int, 2013, 37: 1267-1275.","journal-title":"Cell Biol Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yexcr.2005.09.016","volume":"312","author":"Eliseev RA","year":"2006","unstructured":"Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H, Rosier RN. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF-kappaB. Exp Cell Res, 2006, 312: 40-50.","journal-title":"Exp Cell Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-291X(02)02141-1","volume":"297","author":"Andela VB","year":"2002","unstructured":"Andela VB, Sheu TJ, Puzas EJ, Schwarz EM, O'Keefe RJ, Rosier RN. Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFkappaB. Biochem Biophys Res Commun, 2002, 297: 237-241.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"Yeung F","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J, 2004, 23: 2369-2380.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00198-012-2199-z","volume":"24","author":"Hsiao HB","year":"2013","unstructured":"Hsiao HB, Lin H, Wu JB, Lin WC. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-kappaB pathways. Osteoporos Int, 2013, 24: 1663-1676.","journal-title":"Osteoporos Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"e69468","DOI":"10.1371\/journal.pone.0069468","volume":"8","author":"Liou SF","year":"2013","unstructured":"Liou SF, Hsu JH, Lin IL, Ho ML, Hsu PC, Chen LW, Chen IJ. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-kappaB and calcium\/calcineurin\/NFATc1 pathways. PLoS One, 2013, 8:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00774-013-0530-1","volume":"32","author":"Li DZ","year":"2014","unstructured":"Li DZ, Zhang QX, Dong XX, Li HD, Ma X. Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells. J Bone Miner Metab, 2014, 32: 494-504.","journal-title":"J Bone Miner Metab"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/8D4D6E92E70A477092AFE7BD2F36A892","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu103","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/8D4D6E92E70A477092AFE7BD2F36A892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T20:57:43Z","timestamp":1717534663000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmu103","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}